HDL Cholesterol Kits Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The HDL Cholesterol Kits Market is Segmented by Product Type (HDL and LDL/VLDL Assay Kit and HDL Cholesterol Direct Reagent Kit), by End-User (Hospitals, Diagnostic Laboratories, and Other End users), and by Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

HDL Cholesterol Kits Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

HDL Cholesterol Kits Market Size

HDL Cholesterol Kits Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 6.20 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

HDL Cholesterol Kits Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of HDL Cholesterol Kits Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

HDL Cholesterol Kits Market Analysis

The HDL Cholesterol Kits Market is expected to register a CAGR of 6.2% during the forecast period.

The emergence of the COVID-19 pandemic has had an adverse effect on the world economy and the healthcare system. People with underlying risk conditions and obesity were at greater risk during the COVID-19 pandemic. For instance, as per the data published by the CDC in March 2021, around 30.2% of the total COVID-19 hospitalizations were attributed to obesity. It was observed that obesity had increased exponentially during the pandemic. For instance, an article published in Diabetes, Obesity and Metabolism in August 2021 showed that obesity prevalence is a significant and potentially modifiable risk factor for increased COVID-19 national caseload and mortality. The COVID-19 pandemic restricted patient visits in hospitals and clinics, which decreased the number of cholesterol testing procedures and hence impacted market growth. However, with the release of restrictions and resumed services, the market is expected to increase over the forecast period.

The growing importance of cholesterol screening in obese, hyperlipidemic, and diabetic populations, as well as growing awareness programs for high-risk cholesterol, are expected to drive market growth.

The incidence of obesity has been increasing fiercely over the past decades, and it is often described as a global endemic, especially in developed and developing countries where lifestyle-related disorders, such as anxiety, stress, smoking, and drinking, are more prevalent. Also, obesity is a key risk factor for type 2 diabetes, cardiovascular disease, and hypertension, and it has also been linked to brain illnesses like Alzheimer's disease. For instance, according to the 2021 data published by the WHO, an estimated 38.2 million children under the age of 5 were overweight or obese in 2021. The increasing consumption of junk and processed foods by children decreases the number of vitamins in the body, which is expected to increase the risk of developing high cholesterol. This raises the need to routinely screen cholesterol levels, which is anticipated to propel market growth over the forecast period.

Similarly, according to World Obesity Atlas data from 2022, 27 million children in India are expected to be obese by 2030. Thus, obesity increases the risk of developing high cholesterol due to an unhealthy diet, a lack of exercise, and underlying conditions such as diabetes. This is expected to increase the demand for cholesterol testing in order to reduce the risk of developing cardiovascular disease, fueling the growth of HDL cholesterol test kits over the forecast period.

Furthermore, according to a February 2021 article, dyslipidemia is a major risk factor for cardiovascular disease. Furthermore, an unacceptably high incidence of dyslipidemia has been discovered in Mekelle City's adult population, emphasizing the critical need for early detection and public health interventions through the coordinated involvement of governmental, non-governmental, and public groups. This is expected to increase the population's need for early detection of cholesterol in order to avoid the risks of developing various chronic diseases. Therefore, all the aforementioned factors are expected to fuel market growth.

However, the errors and inaccuracies in HDL cholesterol testing methods are likely to impede the market's growth over the forecast period.

HDL Cholesterol Kits Industry Overview

The HDL cholesterol kit market is moderately competitive and consists of several major players. The major players in the market studied are focusing on expanding their presence in the Asia-Pacific, the Middle East, and Europe through distribution agreements and the opening of new manufacturing facilities. Some of the companies that are currently dominating the market are Abbott, Randox Laboratories Ltd, Thermo Fisher Scientific, Abcam PLC, Merck KGaA, PerkinElmer Inc., Diazyme Laboratories Inc., Cell Biolabs Inc., and Oscar Medicare Pvt. Ltd.

HDL Cholesterol Kits Market Leaders

  1. Abbott Laboratories

  2. Randox Laboratories Ltd.

  3. Thermo Fisher Scientific

  4. Abcam plc

  5. Merck KGaA

  6. *Disclaimer: Major Players sorted in no particular order
HDL Cholesterol Kits Market - Cl.png
Need More Details on Market Players and Competiters?
Download PDF

HDL Cholesterol Kits Market News

  • October 2022: PocDoc, a health technology company, secured the UKCA mark for the digital cholesterol test. By using the PocDoc app on their smartphone, users can deliver a blood test for serious conditions within minutes.
  • September 2022: SiPhox launched Quantify, an at-home test kit and a service that enables users to track 17 health tests (USD 95 per test), including cholesterol testing, sleep, activity, and heart rate data.

HDL Cholesterol Kits Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Importance of Cholesterol Screening in the Obese, Hyperlipidemic, and Diabetic Population
    • 4.2.2 Growing Awareness Programs for High-Risk Cholesterol
  • 4.3 Market Restraints
    • 4.3.1 Errors and Inaccuracy in HDL Cholesterol Testing Methods
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 HDL and LDL/VLDL Assay Kit
    • 5.1.2 HDL Cholesterol Direct Reagent Kit
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Diagnostic Laboratories
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Randox Laboratories Ltd
    • 6.1.3 Thermo Fisher Scientific
    • 6.1.4 Abcam PLC
    • 6.1.5 Merck KGaA
    • 6.1.6 PerkinElmer Inc.
    • 6.1.7 Diazyme Laboratories Inc.
    • 6.1.8 Cell Biolabs Inc.
    • 6.1.9 Oscar Medicare Pvt. Ltd
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

HDL Cholesterol Kits Industry Segmentation

As per the scope of the report, HDL cholesterol kits are fluorometric assays that can measure the amounts of HDL cholesterol present in plasma or serum samples within a 96-well microtiter plate format. The HDL Cholesterol Kits Market is segmented by Product Type (HDL and LDL/VLDL Assay Kit and HDL Cholesterol Direct Reagent Kit), by End User (Hospitals, Diagnostic Laboratories, and Other End Users), and by Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Type HDL and LDL/VLDL Assay Kit
HDL Cholesterol Direct Reagent Kit
By End User Hospitals
Diagnostic Laboratories
Other End Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

HDL Cholesterol Kits Market Research FAQs

What is the current HDL Cholesterol Kits Market size?

The HDL Cholesterol Kits Market is projected to register a CAGR of 6.2% during the forecast period (2025-2030)

Who are the key players in HDL Cholesterol Kits Market?

Abbott Laboratories, Randox Laboratories Ltd., Thermo Fisher Scientific, Abcam plc and Merck KGaA are the major companies operating in the HDL Cholesterol Kits Market.

Which is the fastest growing region in HDL Cholesterol Kits Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in HDL Cholesterol Kits Market?

In 2025, the North America accounts for the largest market share in HDL Cholesterol Kits Market.

What years does this HDL Cholesterol Kits Market cover?

The report covers the HDL Cholesterol Kits Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the HDL Cholesterol Kits Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

HDL Cholesterol Kits Industry Report

Statistics for the 2025 HDL Cholesterol Kits market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. HDL Cholesterol Kits analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

HDL Cholesterol Kits Report Snapshots